Authors



Merrill Matthews, Ph.D.

Latest:

Final Word: Riding on the Coattails of US Patients

In general, people in other countries pay less for brand-name prescription drugs than people in the US. As a result, some Americans travel to Canada or Mexico to get their prescriptions, and an increasing number are using the Internet to buy drugs from other countries.


Bing Zhang

Latest:

Analytical Tools for Process and Product Characterization

Select the best approach to determine critical quality attributes.


Derrick Schertz

Latest:

Mathematical Programming for the Design and Analysis of a Biologics Facility-Part 2

An algorithmic approach to fine tune facility design and predict capacity.


Donna Cassidy-Hanley

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).


M.S. Mahadevan

Latest:

Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine Components

Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.


Suzannah K. Sundby, Esq.

Latest:

Technology Licensing — From First Steps to Executing a Plan

Carefully prosecuted patent applications lead to patents with valid and enforceable claims that provide broad coverage for your technology.


Joseph F. Pekny

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Tod Marvell

Latest:

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.


Bob Rhoades

Latest:

Supplier Quality Management: A Risk-Based Approach

A systematic classification system makes supplier quality management feasible, even if you are dealing with hundreds of suppliers worldwide.


Maria Lusk

Latest:

Build Versus Buy in the Current Biotech Market Environment

How current economic conditions affect your build-or-buy decision.


Jennifer Mercer

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Ellen Leinfuss

Latest:

Ensuring Product Quality and Managing Risk: Validate, Verify, Implement

Biopharmaceutical companies must follow an active approach to managing their supply chains.



Tim Schofield

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Arnold McAuley

Latest:

Best Practices for Formulation and Manufacturing of Biotech Drug Products

How to maintain product stability and prevent particulates.


Geoffrey Hodge

Latest:

Media Development for Mammalian Cell Culture

Once a necessary "magic ingredient" of media for mammalian cell culture, serum is rapidly being eliminated from media for biotherapeutic processes.


Yves Aubin

Latest:

Using NMR Spectroscopy to Obtain the Higher Order Structure of Biopharmaceutical Products

Simple methods can characterize polysaccharide vaccines and recombinant cytokines at high resolution.


Alissa Fernald

Latest:

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.


John Ruesch

Latest:

Use of Contract Analytical Laboratories: A Pfizer Global Biologics Perspective

By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing


Ashot Papoyan

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).


Brad D. Prater

Latest:

Analytical Tools for Process and Product Characterization

Select the best approach to determine critical quality attributes.


Peter K. Watler, PhD

Latest:

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.


Weibin Chen, PhD

Latest:

Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC–MS Methods

Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.


Bruce Meiklejohn

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


D. Howe

Latest:

Effective Auditing of CMOs

It is important that all stages of the audit be given an equal measure of attention.


Eduardo Martínez, PhD

Latest:

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.



Todd Hein

Latest:

QbD: A Roadmap to Adoption

The nimbleness of biotechs makes them well suited to implementing QbD. Here's how to get started.


Yanay Proenza Jimenez

Latest:

High-Cell-Density Culture to Produce Plasmid DNA for Gene Therapy in E. coli

How to produce Plasmid DNA in a high-cell-density culture.

© 2024 MJH Life Sciences

All rights reserved.